Publication:
Two patients with novel missense mutation in the purine nucleoside phosphorylase gene without serious or recurrent infections

dc.contributor.authorÖZEN, AHMET OĞUZHAN
dc.contributor.authorBARIŞ, SAFA
dc.contributor.authorsKiykim A., Simsek I.E., Kiykim E., Karakoc-Aydiner E., Baris S., Ozen A.O., Aydogan M., Santisteban I., Hershfield M., Barlan I.
dc.date.accessioned2022-03-15T02:11:42Z
dc.date.accessioned2026-01-11T16:32:33Z
dc.date.available2022-03-15T02:11:42Z
dc.date.issued2016
dc.description.abstractPurine nucleoside phosphorylase (PNP) deficiency is characterized by T-B+NK+ combined immune deficiency, presenting with neurological deterioration and recurrent infections. PNP is an essential enzyme taking a part in the purine salvage pathway, converting inosine to hypoxanthine, and guanosine to guanine reversibly. We described two patients with PNP deficiency caused by a novel point mutation in exon 5: c.593 C>T, predicting the p.P198L amino acid substitution. Both patients presented with developmental delay and severe lymphopenia without any serious recurrent infections. Children with developmental delay and hypouricemia should be screened for PNP deficiency, especially in the presence of lymphopenia. © 2015 Japanese Society for Neuroimmunology.
dc.identifier.doi10.1111/cen3.12254
dc.identifier.issn17591961
dc.identifier.urihttps://hdl.handle.net/11424/247690
dc.language.isoeng
dc.publisherWiley-Blackwell
dc.relation.ispartofClinical and Experimental Neuroimmunology
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectlymphopenia
dc.subjectneuromotor retardation
dc.subjectpurine nucleoside phosphorylase
dc.subjecturic acid
dc.titleTwo patients with novel missense mutation in the purine nucleoside phosphorylase gene without serious or recurrent infections
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage82
oaire.citation.issue1
oaire.citation.startPage79
oaire.citation.titleClinical and Experimental Neuroimmunology
oaire.citation.volume7

Files